136th Day Of Lockdown

Maharashtra49026232728117092 Tamil Nadu2850242275754690 Andhra Pradesh2069601204641842 Karnataka164924842322998 Delhi1427231282324082 Uttar Pradesh113378668341981 West Bengal89666630601954 Telangana7525753239601 Bihar7179446294400 Gujarat68855517922604 Assam5549737225132 Rajasthan4941835186763 Odisha4255028698292 Haryana4005433444467 Madhya Pradesh3729827621962 Kerala3170019147103 Jammu and Kashmir2392716218449 Punjab1901512491462 Jharkhand140705199129 Chhatisgarh10109761369 Uttarakhand8008484795 Goa7075511460 Tripura5520367528 Puducherry4147253758 Manipur301818147 Himachal Pradesh2879171013 Nagaland24056594 Arunachal Pradesh179011053 Chandigarh120671520 Meghalaya9173305 Sikkim7832971 Mizoram5022820
Business Companies 27 Jun 2019 Bharat Biotech to ma ...

Bharat Biotech to manufacture Cholera vaccine

DECCAN CHRONICLE.
Published Jun 27, 2019, 1:47 am IST
Updated Jun 27, 2019, 1:47 am IST
The vaccine was designed at the University of Gothenburg in Sweden.
Till date, Cholera has been responsible for seven pandemics and accounts for nearly 2.8 million cases and an estimated 95,000 deaths annually. (Representational Image)
 Till date, Cholera has been responsible for seven pandemics and accounts for nearly 2.8 million cases and an estimated 95,000 deaths annually. (Representational Image)

Hyderabad: Global research and development organization Hilleman Laboratories on Wednesday announced that it will further develop and manufacture its next-generation oral Cholera vaccine Hillchol in collaboration with city-based Bharat Biotech.

The vaccine was designed at the University of Gothenburg in Sweden. It was subsequently developed by Hilleman Labs.  Now, Hilleman Labs will collaborate with Bharat Biotech as it looks to bag the WHO pre-qualification tag for the vaccine. The collaboration aims strengthen the ability of both organisations towards prevention of Cholera in low and middle-income countries.

 

Till date, Cholera has been responsible for seven pandemics and accounts for nearly 2.8 million cases and an estimated 95,000 deaths annually. In India, about 30 per cent of the population still remains at risk from Cholera.

Bharat Biotech will scale the manufacturing process to commercial stage.

...
Location: India, Telangana, Hyderabad




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT